首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷 CT/MRI/X光

造影乳房X光攝影市場規模、佔有率及成長分析（按應用、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1904372

造影乳房X光攝影市場規模、佔有率及成長分析（按應用、最終用戶和地區分類）－2026-2033年產業預測

Contrast Enhanced Mammography Market Size, Share, and Growth Analysis, By Applications (Screening, Diagnosis), By End User (Hospital, Diagnostic Centres), By Region - Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，造影乳房攝影市場規模將達到 24.4 億美元，到 2025 年將達到 25.9 億美元，到 2033 年將達到 41.2 億美元，預測期（2026-2033 年）的複合年成長率為 6%。

造影增強乳房X光攝影（CEM）採用雙能量技術，協同發揮數位乳房X光攝影和靜脈造影顯影劑的優勢，在乳癌檢測方面比傳統方法具有更高的靈敏度。由於全球乳癌發生率不斷上升，CEM 已成為首選的診斷方法。乳癌的危險因子包括年齡、肥胖、家族病史和各種生活方式選擇，主要影響女性。早期發現至關重要，因為乳癌的症狀從乳房腫塊和大小變化到淋巴結腫大和呼吸問題等更嚴重的症狀不等。乳癌發生率的上升凸顯了對 CEM 等先進影像診斷技術的重要性和需求，顯著推動了醫療保健產業的市場成長。

對比增強造影市場促進因素

推動造影X光檢查市場成長的關鍵因素是乳癌發生率的不斷上升，乳癌是全球女性最常見的癌症。早期發現對於有效控制乳癌至關重要，並能提供多種治療方案。患者通常接受手術、放射線治療和各種藥物治療的聯合治療，包括荷爾蒙療法、化療和生物目標療法。這些干預措施對於抑制癌症生長和減輕其影響至關重要，最終能夠提高存活率並改善患者在對抗這種常見疾病中的預後。

造影乳房X光檢查市場限制因素

對比增強造影X光乳房X光攝影的應用面臨諸多挑戰。首要挑戰在於其成本高於傳統乳房X光攝影，這主要是由於需要昂貴的設備、材料和專業培訓。此外，提供這項先進影像技術的機構數量有限，導致患者難以獲得相關服務，尤其對於居住在農村和偏遠地區的患者。臨床應用前需要獲得監管部門的核准，這進一步增加了複雜性。核准流程可能耗時高成本，延遲產品上市。此外，儘管早期臨床研究顯示出令人鼓舞的結果，但由於缺乏關於該技術療效和安全性的長期數據，一些醫療機構可能會在獲得更多證據之前對其應用持謹慎態度。

造影乳房X光攝影市場的發展趨勢

造影乳房X光攝影市場正經歷顯著成長，這主要得益於女性乳癌發病率的上升以及由此產生的對先進診斷解決方案的需求。效率更高、準確度更強、可靠性更高的創新影像技術不斷湧現，顯著提升了乳癌的檢測和診斷能力。這一趨勢反映了精準醫療的廣泛發展趨勢，醫療機構正尋求應用尖端技術，不僅以改善患者預後，還能簡化診斷流程。隨著人們對乳癌的認知不斷提高以及技術的持續進步，預計該市場將繼續擴張，為醫學影像領域的相關人員帶來新的機會。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

GE Healthcare（USA）
Siemens Healthineers（Germany）
Hologic, Inc.（USA）
Fujifilm Holdings Corporation（Japan）
Canon Medical Systems Corporation（Japan）
Philips Healthcare（Netherlands）
Carestream Health（USA）
Konica Minolta, Inc.（Japan）
Planmed Oy（Finland）
Sectra AB（Sweden）
Gamma Medica-Ideas, Inc.（USA）
SuperSonic Imagine（France）
iCAD, Inc.（USA）
ScreenPoint Medical（Netherlands）
DeepHealth（USA）
Lunit Inc.（South Korea）
CureMetrix, Inc.（USA）
Bracco Imaging SpA（Italy）
Guerbet（France）

結論與建議

簡介目錄

Product Code: SQMIG35G2123

Contrast Enhanced Mammography Market size was valued at USD 2.44 Billion in 2024 and is poised to grow from USD 2.59 Billion in 2025 to USD 4.12 Billion by 2033, growing at a CAGR of 6% during the forecast period (2026-2033).

Contrast Enhanced Mammography (CEM) utilizes a dual-energy technique that synergizes the advantages of digital mammography with intravenous contrast, proving to be more sensitive in breast cancer detection than traditional methods. The increasing prevalence of breast cancer globally positions CEM as a preferred diagnostic approach. Risk factors for breast cancer include age, obesity, family history, and various lifestyle choices, predominantly affecting females. Given that breast cancer symptoms can range from lumps and changes in breast size to more severe issues like lymph node swelling and respiratory problems, early detection is critical. This growing incidence of breast cancer underlines the importance and demand for advanced imaging technologies like CEM, thus significantly driving market growth in the healthcare sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Contrast Enhanced Mammography market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Contrast Enhanced Mammography Market Segments Analysis

Global Contrast Enhanced Mammography Market is segmented by Applications, End User and region. Based on Applications, the market is segmented into Screening and Diagnosis. Based on End User, the market is segmented into Hospital, Diagnostic Centres, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Contrast Enhanced Mammography Market

A significant factor propelling the growth of the Contrast Enhanced Mammography market is the increasing prevalence of breast cancer, which stands as the most frequently diagnosed cancer among women on a global scale. Early detection plays a critical role in effectively managing breast cancer, allowing for a range of treatment options. Patients typically undergo a combination of surgery, radiation therapy, and various medications, including hormone therapy, chemotherapy, and targeted biological therapies. These interventions are crucial in controlling cancer's proliferation and mitigating its impact, ultimately enhancing survival rates and improving patient outcomes in the battle against this pervasive disease.

Restraints in the Contrast Enhanced Mammography Market

The adoption of contrast-enhanced mammography faces several challenges, primarily due to its higher costs in comparison to traditional mammography, which stems from the expensive equipment, materials, and specialized training required. Additionally, the limited availability of facilities that offer this advanced imaging technique presents accessibility issues, especially for patients located in rural or remote areas. The necessity for regulatory approval prior to clinical use adds another layer of complexity, often involving prolonged and costly processes that can delay market entry. Moreover, although initial clinical studies have shown promising outcomes, the absence of extensive long-term data regarding the technology's efficacy and safety may lead some healthcare providers to be cautious about its implementation until further evidence is presented.

Market Trends of the Contrast Enhanced Mammography Market

The Contrast Enhanced Mammography market is witnessing significant growth, driven by the increasing incidence of breast cancer among women and the corresponding demand for advanced diagnostic solutions. Innovative imaging technologies are emerging, enhancing breast cancer detection and diagnostic capabilities with superior efficiency, accuracy, and reliability. This trend reflects a broader shift toward precision medicine, with healthcare providers seeking to adopt cutting-edge methods that not only improve patient outcomes but also streamline the diagnostic process. As awareness of breast cancer grows and technological advancements continue, the market is set to expand, offering new opportunities for stakeholders in the medical imaging field.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Contrast Enhanced Mammography Market Size by Applications & CAGR (2026-2033)

Market Overview
Screening
Diagnosis

Global Contrast Enhanced Mammography Market Size by End User & CAGR (2026-2033)

Market Overview
Hospital
Diagnostic Centres
Specialty Clinics
Others

Global Contrast Enhanced Mammography Market Size & CAGR (2026-2033)

North America (Applications, End User)
- US
- Canada
Europe (Applications, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Applications, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Applications, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Applications, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

GE Healthcare (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Canon Medical Systems Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philips Healthcare (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Carestream Health (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Konica Minolta, Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Planmed Oy (Finland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sectra AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gamma Medica-Ideas, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SuperSonic Imagine (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
iCAD, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ScreenPoint Medical (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DeepHealth (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lunit Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CureMetrix, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bracco Imaging S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Guerbet (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments